CureVac Receives Grants for Three Patents Regarding Intratumoral Application of RNA

NEXT STORY
G1 Therapeutics Announces Updates to Board of Directors
PREV STORY
First Patient Dosed with Gevokizumab in Collaborator Clinical Study in Metastatic Colorectal Cancer, Gastroesophageal Cancer, and Renal Cell Carcinoma
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

CureVac Receives Grants for Three Patents Regarding Intratumoral Application of RNA

NEXT STORY
G1 Therapeutics Announces Updates to Board of Directors
PREV STORY
First Patient Dosed with Gevokizumab in Collaborator Clinical Study in Metastatic Colorectal Cancer, Gastroesophageal Cancer, and Renal Cell Carcinoma
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

EMA issues advice on casirivimab and imdevimab antibody cocktail for the treatment of mild-to-moderate COVID-19

author_avatar
NASDAQ Market News

Nanobiotix announces its clinical registration plan in Head and Neck cancers for the United States following FDA feedback

author_avatar
NASDAQ Market News

Trevena, Inc. Announces Presentations of OLINVYK™ Health Economic Models at AMCP 2021 Annual Meeting

author_avatar
NASDAQ Market News